For condition: Eczema
For condition: ECZEMA - ATOPIC DERMATITIS
Adults’ Eczema Study (57 Weeks)
Study Summary
Who Can Participate?
Adults aged 18 to 75 with moderate to severe eczema (atopic dermatitis) may participate.
Inclusion Criteria
• Body weight ≥40 kg (88.2 pounds)
• Has chronic Atopic Dermatitis (AD) that has been present for ≥1 year
• Has required systemic therapy to achieve adequate control of AD, OR topical medications are medically inadvisable (e.g., because of
important side effects, safety risks, and/or previous intolerance), OR has a history of inadequate response to treatment with topical
medications for at least 28 days
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating eczema (14 visits)
• Will receive both an investigative subcutaneous treatment (study drug) and a placebo
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
57 weeks
For more information about this trial, please visit ClinicalTrials.gov
